Tyroscope Co., Ltd. (CEO Park Jae-min) announced that it will participate in ‘BIO KOREA 5 (Bio Korea 10)’, which will be held at COEX in Seoul for three days from Wednesday, May 12th to Friday, May 3th.
Tyroscope, a venture company established in 2020, developed the world’s first thyroid disease integrated smart care solution ‘Glandy’ and commercialized it as a mobile application (app), drawing industry attention. The Wellness version of the app has now been released in Korea, and for the thyroid dysfunction risk monitoring and thyroid ophthalmopathy risk monitoring solution corresponding to software medical devices, the process of obtaining approval from the Korean Ministry of Food and Drug Safety and the US FDA and European CE certification has been completed. It’s going on at the same time.
In addition, based on clinical research conducted by our Chief Technology Officer (CTO), Professor Jaehoon Moon of the Department of Endocrinology at Seoul National University Bundang Hospital, since 2016, we have utilized ‘thyroid hormone risk prediction technology using heart rate’ to advance and commercialize the technology. is reportedly in progress.
In this exhibition, Tyroscope, along with its company Glandy, introduces the ‘Healthy Sam’ service, an app exclusively for domestic thyroid hospitals.
Glandy is an app that assists users in self-management of thyroid disease. It provides functions such as resting heart rate monitoring, customized medication management, blood test record tracking and change confirmation, and thyroid ophthalmopathy management. In addition, the patient community function allows communication with other patients about the disease, and the thyroid magazine and disease-related Q&A function help users resolve their individual questions.
Healthy Sam, a patient management system for hospitals and clinics that will be introduced together, consists of an app dedicated to local thyroid hospitals and a webpage dedicated to attending physicians. Blood test values are automatically linked so the patient can check the test results and the doctor’s comments, and the doctor can check the information and charts recorded by the patient through the app through the web page, making it easier to provide customized diagnosis, treatment, and management to the patient. You can.
At the same time, patients can use the medication reminder function by specifically setting the type, dose, and time of thyroid medication, or easily check medication status and compliance. In addition, this is also a patient community service where disease conditions and information can be shared with thyroid patients across the country, and each patient can resolve questions related to the disease through a health mentor.
A Tyroscope official said, “We planned to operate a booth during the exhibition and participate in business partnering events to discover domestic and foreign clinical trial cooperation hospitals for Glandy’s medical device approval. “At the same time, we hope to find partners who will cooperate in commercialization after approval, including global pharmaceutical companies specializing in anti-inflammatory drugs, wearable solution manufacturers, and telemedicine monitoring platform companies,” he said.
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, is hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. It goes on.